6748 related articles for article (PubMed ID: 2557603)
21. [111In]-DTPA-labeled analogues of alpha-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo.
Bagutti C; Stolz B; Albert R; Bruns C; Pless J; Eberle AN
Int J Cancer; 1994 Sep; 58(5):749-55. PubMed ID: 8077062
[TBL] [Abstract][Full Text] [Related]
22. Discovery and structure-activity relationships of novel alpha-melanocyte-stimulating hormone inhibitors.
Sawyer TK; Staples DJ; Castrucci AM; Hadley ME
Pept Res; 1989; 2(1):140-6. PubMed ID: 2562482
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, biology, and conformations of bicyclic alpha-melanotropin analogues.
Haskell-Luevano C; Shenderovich MD; Sharma SD; Nikiforovich GV; Hadley ME; Hruby VJ
J Med Chem; 1995 May; 38(10):1736-50. PubMed ID: 7752197
[TBL] [Abstract][Full Text] [Related]
24. Alpha-melanocyte stimulating hormone message and inhibitory sequences: comparative structure-activity studies on melanocytes.
Sawyer TK; Staples DJ; Castrucci AM; Hadley ME; al-Obeidi FA; Cody WL; Hruby VJ
Peptides; 1990; 11(2):351-7. PubMed ID: 2162535
[TBL] [Abstract][Full Text] [Related]
25. Cyclic melanotropins. 5. Importance of the C-terminal tripeptide (Lys-Pro-Val).
Cody WL; Wilkes BC; Muska BJ; Hruby VJ; Castrucci AM; Hadley ME
J Med Chem; 1984 Sep; 27(9):1186-90. PubMed ID: 6332195
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological activities of fatty acid conjugates of a cyclic lactam alpha-melanotropin.
al-Obeidi F; Hruby VJ; Yaghoubi N; Marwan MM; Hadley ME
J Med Chem; 1992 Jan; 35(1):118-23. PubMed ID: 1732518
[TBL] [Abstract][Full Text] [Related]
27. The melanotropic peptide, [Nle4,D-Phe7] alpha-MSH, stimulates human melanoma tyrosinase activity and inhibits cell proliferation.
Jiang J; Sharma SD; Nakamura S; Lai JY; Fink JL; Hruby VJ; Hadley ME
Pigment Cell Res; 1995 Dec; 8(6):314-23. PubMed ID: 8789740
[TBL] [Abstract][Full Text] [Related]
28. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin that "irreversibly" activates melanoma tyrosinase.
Hadley ME; Abdel Malek ZA; Marwan MM; Kreutzfeld KL; Hruby VJ
Endocr Res; 1985; 11(3-4):157-70. PubMed ID: 3009169
[TBL] [Abstract][Full Text] [Related]
29. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin with prolonged action on vertebrate chromatophores.
Hadley ME; Mieyr JH; Martin BE; Castrucci AM; Hruby VJ; Sawyer TK; Powers EA; Rao KR
Comp Biochem Physiol A Comp Physiol; 1985; 81(1):1-6. PubMed ID: 2859941
[TBL] [Abstract][Full Text] [Related]
30. Comparative biological activities of potent analogues of alpha-melanotropin. Effect of nonaromatic and para substituted aromatic amino acids at position 7.
Wilkes BC; Cody WL; Hruby VJ; Castrucci AM; Hadley ME
Int J Pept Protein Res; 1986 Jun; 27(6):685-94. PubMed ID: 3489682
[TBL] [Abstract][Full Text] [Related]
31. Relative stability of alpha-melanotropin and related analogues to rat brain homogenates.
Akiyama K; Yamamura HI; Wilkes BC; Cody WL; Hruby VJ; Castrucci AM; Hadley ME
Peptides; 1984; 5(6):1191-5. PubMed ID: 6531272
[TBL] [Abstract][Full Text] [Related]
32. beta-Methylation of the Phe7 and Trp9 melanotropin side chain pharmacophores affects ligand-receptor interactions and prolonged biological activity.
Haskell-Luevano C; Toth K; Boteju L; Job C; Castrucci AM; Hadley ME; Hruby VJ
J Med Chem; 1997 Aug; 40(17):2740-9. PubMed ID: 9276019
[TBL] [Abstract][Full Text] [Related]
33. Characterizations of the unusual dissociation properties of melanotropin peptides from the melanocortin receptor, hMC1R.
Haskell-Luevano C; Miwa H; Dickinson C; Hadley ME; Hruby VJ; Yamada T; Gantz I
J Med Chem; 1996 Jan; 39(2):432-5. PubMed ID: 8558511
[TBL] [Abstract][Full Text] [Related]
34. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.
Sawyer TK; Sanfilippo PJ; Hruby VJ; Engel MH; Heward CB; Burnett JB; Hadley ME
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5754-8. PubMed ID: 6777774
[TBL] [Abstract][Full Text] [Related]
35. [half-Cys4,half-Cys10]-alpha-Melanocyte-stimulating hormone: a cyclic alpha-melanotropin exhibiting superagonist biological activity.
Sawyer TK; Hruby VJ; Darman PS; Hadley ME
Proc Natl Acad Sci U S A; 1982 Mar; 79(6):1751-5. PubMed ID: 6281785
[TBL] [Abstract][Full Text] [Related]
36. Comparative biological activities of alpha-MSH antagonists in vertebrate pigment cells.
Castrucci AM; Almeida AL; al-Obeidi FA; Hadley ME; Hruby VJ; Staples DJ; Sawyer TK
Gen Comp Endocrinol; 1997 Mar; 105(3):410-6. PubMed ID: 9073503
[TBL] [Abstract][Full Text] [Related]
37. Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists.
Haskell-Luevano C; Sawyer TK; Trumpp-Kallmeyer S; Bikker JA; Humblet C; Gantz I; Hruby VJ
Drug Des Discov; 1996 Dec; 14(3):197-211. PubMed ID: 9017363
[TBL] [Abstract][Full Text] [Related]
38. Enzymological studies of melanotropins.
Castrucci AM; Hadley ME; Sawyer TK; Hruby VJ
Comp Biochem Physiol B; 1984; 78(3):519-24. PubMed ID: 6332706
[TBL] [Abstract][Full Text] [Related]
39. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
[TBL] [Abstract][Full Text] [Related]
40. Topographical modification of melanotropin peptide analogues with beta-methyltryptophan isomers at position 9 leads to differential potencies and prolonged biological activities.
Haskell-Luevano C; Boteju LW; Miwa H; Dickinson C; Gantz I; Yamada T; Hadley ME; Hruby VJ
J Med Chem; 1995 Nov; 38(23):4720-9. PubMed ID: 7473600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
